Structural Heart Devices Market is expected to reach US$ XX Bn by 2026 at a CAGR of 10.5% during the forecast period.
The structural heart devices market has gained demand in recent years due to the uncompromising rise in mitral regurgitation, aortic stenosis, and other related heart diseases.
A rise in the incidence of aortic stenosis, increase in awareness about the benefits and availability of structural heart devices worldwide, and the introduction of technologically advanced products (such as the Trifecta valve with Glide Technology) has driven the market demand of structural heart devices market. Healthcare expenditure and the growing geriatric population are expected to create market opportunities for the structural heart devices in the future as well. Furthermore, stringent approval process and a high cost of surgeries may hamper the growth of the market acting as some of the major restraints for the market growth.
Structural heart devices market is segmented by product, procedure, and region. Among procedures, surgical aortic valve replacement (SAVR), transcatheter aortic valve replacement (TAVR) segment market accounted for the XX% share in 2018. Surgical aortic valve replacement dominated in 2018 due to its proved efficacy in the treatment and established reimbursement codes.
Based on products, surgical heart valves product is expected to be one of the fastest growing segments in the forecast period. The minimally invasive surgical nature of the procedure is the key reason for this rapid growth.
Among regions, the North America region is expected to grow at the XX5 CAGR during the forecast period due to a high prevalence of cardiovascular disease, increasing adoption of angiographic procedures and rising demand of accurate diagnosis. The Asia Pacific region is expected to grow at the XX% CAGR during the forecast period due to the increasing awareness of cardiac diseases, better newborn screening programs, and improvement in healthcare access.
There is a sturdy growth in the production as new companies are entering the structural heart market. For example, in May 2016, a leading medical devices company, Edwards Lifesciences Corporation (US) announced its intentions to enter the structural heart market.
In the structural heart devices market, Boston Scientific Corporation holds the leading position due to production capacity expansion, brand portfolio expansion, mergers, collaborations, and acquisitions. In 2018, the company has adopted new product launches, product enhancements, and geographic expansion as its crucial business plans to certify its dominance in this market.
The objective of the report is to present comprehensive analysis of Structural Heart Devices market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
The report also helps in understanding Structural Heart Devices market dynamics, structure by analyzing the market segments, and project the Structural Heart Devices market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Structural Heart Devices market make the report investor’s guide.
The scope of Structural Heart Devices Market report:
• Structural Heart Devices Market, by Product
• Heart Valve Devices
• Surgical Heart Valves
• Transcatheter Heart Valves
• Occluders and Delivery Systems
• Annuloplasty Rings
• Other Devices
• Structural Heart Devices Market, by Procedure
• Replacement Procedures
• TAVR Procedures
• SAVR Procedures
• Repair Procedures
• Closure Procedures
• TMVR Procedures
• Structural Heart Devices Market, By Region
• North America
• Latin America
• Key Players, Structural Heart Devices Market
• Edwards Lifesciences Corporation
• Medtronic plc
• Boston Scientific Corporation
• LivaNova plc (UK).
• Comed BV
• LivaNova PLC
• JenaValve Technology, Inc.
For More Information Visit @:https://www.maximizemarketresearch.com/market-report/structural-heart-devices-market/13692/
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Name: Lumawant Godage
Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.
Address: Pune, Maharashtra 411051, India.